The PET Scanners Market size was estimated USD 2.0 billion in 2022 and is expected to reach USD 3.02 billion by 2030 at a CAGR of 5.3% during the forecast period of 2023-2030.
The Positron Emission Tomography (PET) Scanners market is expected to grow in the forecast, owing to factors such as technological advancements, advantages such as increased storage capacity, increased efficiency in terms of scanning time reduction and increasing availability of value-based and technologically developed PET machines. Nonetheless, a lack of radiopharmaceutical supply is projected to limit market expansion throughout the projection period.
DRIVERS
High Adoption of Oncological Disease Management to Aid Market Growth
The increased knowledge about the benefits of radiation oncology and radiotherapy, as well as rising demand for non-invasive procedures globally, the global positron emission tomography (PET) scanners market is expected to have a promising future throughout the assessment period. During the assessment period, the rising use of radiation oncology to treat a variety of oncological diseases and enhance target volume delineation for radiotherapy operations in the pipeline is predicted to increase demand for positron emission tomography (PET) scanners.
Hardware advancements and advances in PET instrumentation will drive market growth.
PET instrumentation has progressed at a remarkable rate in recent years, attracting great attention in the medical imaging field. Some of the most notable breakthroughs are the creation of new hardware, the integration of designs with digital photomultipliers, and the development of rapid electronics, which have enabled the application of time-of-light reconstruction. Furthermore, market participants in the positron emission tomography (PET) scanners landscape have become increasingly focused on enhancing PET sensitivity, which necessitates 3D imaging and a broader axial field. Significant efforts have been made to increase the use of positron emission tomography (PET) scanners for cardiac and respiratory patients in order to improve overall imaging quality and resolution.
RESTRAIN
Stringent Regulatory Guidelines to Restrain the Positron Emission Tomography (PET) Scanners market
Radioisotope production, storage, and use necessitate suitable precautions since radioisotopes emit radiation that can harm the general people and the environment. Any use, storage, or manufacturing of radioisotopes requires approval from the Food and Drug Administration and the Medicines and Healthcare Products Regulatory Agency. The Nuclear Regulatory Commission maintains roughly 6,000 licenses for the use of radioactive materials; violations of agreement result in enforcement measures, including license revocation.
OPPORTUNITY
Innovation of 3D laser scanners and the rapidly growing mining industry propel market opportunities.
The increasing use of PET and X-ray transmission computed tomography (CT) scans is likely to drive the industry forward.
This cutting-edge technology shortens acquisition time while also providing precise attenuation correction and fusion imaging, resulting in high diagnostic sensitivity and specificity within the next few years. Furthermore, the combination of PET and CT aids in disease staging by defining prognostic and treatment monitoring capabilities of functional and metabolic information provided by traditional nuclear imaging modalities. Fluorodeoxyglucose (FDG) is commonly used in PET scanning procedures because it may record tissue glucose metabolism and boost its characteristics. However, fluorodeoxyglucose has a few drawbacks, including limited specificity.
In addition, numerous possible radiotracers are being researched to answer unmet clinical needs in disease diagnostics. In response, manufacturers are releasing new products with increased sensitivity to metabolic activity in order to perform thorough scans. In order to improve their product portfolios, players are increasingly engaging in mergers and acquisitions.
CHALLENGES
Expensive installation and maintenance
Ukraine's health-care system has suffered since the beginning of the conflict. The logistics of assisting all patients, particularly those with combined cardiovascular pathology and oncology, severe pulmonary hypertension, and others in need of special surveillance, were eliminated. Many of these individuals were saved and continued treatment in foreign facilities thanks to the efforts of specialists and the assistance of international finances. Medical services have been severely hampered. According to the World Health Organization Surveillance System for Attacks on Health Care, there had been 715 verified attacks against health care facilities (600 with heavy weapons), personnel, patients, transportation, and supply depots as of December 7, 2022, kiting 100 people and wounding 129. As of this writing, 127 facilities had been entirely destroyed and could not be rebuilt. The medical infrastructure was most severely damaged in five locations. This tremendous destruction adds to the effects of the war on medical supply manufacturing and procurement, as well as the issues posed by the displacement of doctors and nurses.
IMPACT OF ONGOING RECESSION
Economic downturns can result in drastic and abrupt changes in socioeconomic position (SEP) in particular segments of the general population. The consequences are known as socioeconomic troubles, and they might influence social or financial domains in people's life at home or at work. Although there is a well-established literature on the function of SEP in the development of CVD during the normal life cycle, just a few research have looked into the involvement of economic recessions in CVD morbidity and mortality. Prior research findings are contentious and inconclusive. Few studies have found that recessions increase the risk of incident CVD in the future and raise CVD mortality rates during the recession period. However, other research has suggested that CVD mortality may even reduce during recessions. Surprisingly, the majority of those studies solely looked at unemployment to assess the hardships imposed by recessions.
By Modality
PET-CT
PET-MRI
In 2022, the PET-CT segment is expected to held the highest market revenue share of 81.8% during the forecast period, also the segment is registering the fastest CAGR of 5.4% over the forecast period. A PET-CT combines two different scanning procedures, a regular CT scan and a PET scan, into one examination using computer software and modern imaging technologies. A PET scanner uses gamma radiation from radioactive tracers to generate 3-dimensional (3D), color images of the functional activities within the human body to identify disorders, whereas other methods generate images using sound waves or x-rays. A PET/CT scanner, by combining these two scanning technologies, enables clinicians to discover, plan therapy for, and monitor diseases earlier and more precisely.
Furthermore, leading market players are attempting to deliver a wider choice of improved imaging goods combined with new technology, which is fueling the growth of the PET scanners market. For example, GE Healthcare, a leading provider of healthcare devices, unveiled "Omni" in October 2022, its sophisticated PET/CT platform meant to improve operational efficiency. According to the company, the Omni, PET/CT platform was created to help the healthcare sector overcome problems by collecting intuitive workflow solutions enhanced by artificial intelligence (AI), including its AI-based Auto Positioning Camera and innovative Precision DLi solution for deep learning image processing in PET/CT.
By Application
Oncology
Cardiology
Neurology
Others
In 2022, the oncology segment is accounted for the largest market share of 47.1% during the forecast period due to the rising global prevalence of cancer cases and the growing demand for effective and economical diagnostic methods that reduce radiation exposure. According to a scholarly paper published in "A Cancer Journal for Clinicians" by the American Cancer Society. In 2021, a projected 1.9 million new cancer cases will be diagnosed, with 608,570 deaths attributable to cancer in the United States. PET scanners employ a radioactive medication or tracer that detects abnormal as well as normal metabolic activity. It can also detect aberrant tracer metabolism in conditions before the disease manifests itself on other imaging tests.
By End User
Hospitals
Diagnostic Imaging Centers
Academic & Research Institutes
.png)
In 2022, the hospitals segment is expected to dominate the market share of 47.2% during the forecast period due to hospitals have a relatively high patient volume and access to advanced diagnostic equipment that other healthcare institutions may not have, such as advanced PET scanners, allowing them to provide comprehensive medical care to patients. In addition, hospitals have formed referral networks with insurance companies. PET scans are a costly diagnostic tool that is often covered by health insurance; thus, patients can utilize their health insurance for PET scans performed in hospitals.
North America held a significant market revenue share of 34.3% in 2022. This is due to the region's advanced healthcare infrastructure and quick technology breakthroughs in the medical imaging and diagnostic sector. Furthermore, the existence of big corporations, mergers between key competitors, new product launches, and FDA approvals are projected to boost worldwide market expansion.
Furthermore, the improved spending capacities of governments in the North American region may have a favorable impact on the region's PET scanner industry. For example, the Western Regional facility Foundation in Canada received USD 2 million from the provincial government in January 2021 to be used to purchase a PET scanner for the new intensive care facility in Corner Brook. The declaration was issued by the Ministers of Health and Community Services, Immigration, Skills, and Labor, as well as the MHA for Corner Brook. The Western Regional Hospital Foundation will hold USD 2 million in trust for the construction of a PET scanner, demonstrating the growing and innovative nature of health care in the region.
Asia-Pacific is witness to expand fastest CAGR rate of 6.0% during the forecast period due to the region's rapid economic expansion is projected to fuel demand for innovative and individualized technology, as well as efforts to supply the most appropriate solutions and products for the imaging and diagnostic sectors. Furthermore, expanding medical device companies providing advanced healthcare solutions in highly populous Asian countries such as Japan, China, and India are providing potential market opportunities and attracting stakeholders to expand their portfolios in the Asia Pacific medical imaging and PET scanners market.
REGIONAL COVERAGE
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
The major key players are Siemens Healthineers, GE Healthcare, Koninklijke Phillips N.V., Canon Medical Systems, USA., Mediso Ltd., Shimadzu Corporation, Neusoft Medical Systems Co., Ltd., MinFound Medical Systems Co., Ltd, Perkin Elmer, Inc., Positron Corporation, Yangzhou Kindsway Biotech Co. Ltd., and Others.
In March 2022, PluvictoTM was approved by the FDA for Novartis, a prominent pharmaceutical business. According to the business, "Pluvicto" was the first FDA-approved targeted radioligand therapy (RLT), and it aids in the treatment of patients with PSMA-positive metastatic castration-resistant prostate cancer (PSMA-positive mCRPC).
In July 2021, G.E. Healthcare has partnered with Quibim, Oncovision, and Full Body Insight to develop innovative PET/CT total-body scanners for whole-body imaging.
In April 2021, according to the World Nuclear Association, around 10,000 hospitals worldwide employ radioisotopes in medicine, with approximately 90% of the treatments being diagnostic.
In March 2021, Siemens Healthineers' Biograph Vision Quadra, a new PET/CT scanner with a broad axial field of view of 106 cm, has received FDA approval in the United States.
|
Report Attributes |
Details |
|
Market Size in 2022 |
US$ 2.0 billion |
|
Market Size by 2030 |
US$ 3.02 billion |
|
CAGR |
CAGR of 5.3% From 2023 to 2030 |
|
Base Year |
2022 |
|
Forecast Period |
2023-2030 |
|
Historical Data |
2019-2021 |
|
Report Scope & Coverage |
Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
|
Key Segments |
By Modality (PET-CT, PET-MRI), By Application (Oncology, Cardiology, Neurology, Others), By End User (Hospitals, Diagnostic Imaging Centers, Academic & Research Institutes) |
|
Regional Analysis/Coverage |
North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia Rest of Latin America) |
|
Company Profiles |
Siemens Healthineers, GE Healthcare, Koninklijke Phillips N.V., Canon Medical Systems, USA., Mediso Ltd., Shimadzu Corporation, Neusoft Medical Systems Co., Ltd., MinFound Medical Systems Co., Ltd, Perkin Elmer, Inc., Positron Corporation, Yangzhou Kindsway Biotech Co. Ltd. |
|
Key Drivers |
• Hardware advancements and advances in PET instrumentation will drive market growth. |
|
Market Opportunties |
•The increasing use of PET and X-ray transmission computed tomography (CT) scans is likely to drive the industry forward. |
PET scanners market size was valued at USD 2.0 billion in 2022.
The growth rate of PET scanners market is expected to grow USD 3.02 billion by 2030.
PET scanners market is anticipated to expand by 5.3% from 2023 to 2030.
Stringent Regulatory Guidelines to Restrain the Positron Emission Tomography (PET) Scanners market.
The increasing use of PET and X-ray transmission computed tomography (CT) scans is likely to drive the industry forward.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 Impact of the Ukraine- Russia war
4.2 Impact of ongoing Recession
4.2.1 Introduction
4.2.2 Impact on major economies
4.2.2.1 US
4.2.2.2 Canada
4.2.2.3 Germany
4.2.2.4 France
4.2.2.5 United Kingdom
4.2.2.6 China
4.2.2.7 Japan
4.2.2.8 South Korea
4.2.2.9 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. PET Scanners Market Segmentation, By Modality
8.1 Hard PET-CT
8.2 PET-MRI
9. PET Scanners Market Segmentation, By Application
9.1 Oncology
9.2 Cardiology
9.3 Neurology
9.4 Others
10. PET Scanners Market Segmentation, By End User
10.1 Hospitals
10.2 Diagnostic Imaging Centers
10.3 Academic & Research Institutes
11. Regional Analysis
11.1 Introduction
11.2 North America
11.2.1 North America PET Scanners Market by Country
11.2.2North America PET Scanners Market by Modality
11.2.3 North America PET Scanners Market by Application
11.2.4 North America PET Scanners Market by End User
11.2.5 USA
11.2.5.1 USA PET Scanners Market by Modality
11.2.5.2 USA PET Scanners Market by Application
11.2.5.3 USA PET Scanners Market by End User
11.2.6 Canada
11.2.6.1 Canada PET Scanners Market by Modality
11.2.6.2 Canada PET Scanners Market by Application
11.2.6.3 Canada PET Scanners Market by End User
11.2.7 Mexico
11.2.7.1 Mexico PET Scanners Market by Modality
11.2.7.2 Mexico PET Scanners Market by Application
11.2.7.3 Mexico PET Scanners Market by End User
11.3 Europe
11.3.1 Eastern Europe
11.3.1.1 Eastern Europe PET Scanners Market by Country
11.3.1.2 Eastern Europe PET Scanners Market by Modality
11.3.1.3 Eastern Europe PET Scanners Market by Application
11.3.1.4 Eastern Europe PET Scanners Market by End User
11.3.1.5 Poland
11.3.1.5.1 Poland PET Scanners Market by Modality
11.3.1.5.2 Poland PET Scanners Market by Application
11.3.1.5.3 Poland PET Scanners Market by End User
11.3.1.6 Romania
11.3.1.6.1 Romania PET Scanners Market by Modality
11.3.1.6.2 Romania PET Scanners Market by Application
11.3.1.6.4 Romania PET Scanners Market by End User
11.3.1.7 Turkey
11.3.1.7.1 Turkey PET Scanners Market by Modality
11.3.1.7.2 Turkey PET Scanners Market by Application
11.3.1.7.3 Turkey PET Scanners Market by End User
11.3.1.8 Rest of Eastern Europe
11.3.1.8.1 Rest of Eastern Europe PET Scanners Market by Modality
11.3.1.8.2 Rest of Eastern Europe PET Scanners Market by Application
11.3.1.8.3 Rest of Eastern Europe PET Scanners Market by End User
11.3.2 Western Europe
11.3.2.1 Western Europe PET Scanners Market by Modality
11.3.2.2 Western Europe PET Scanners Market by Application
11.3.2.3 Western Europe PET Scanners Market by End User
11.3.2.4 Germany
11.3.2.4.1 Germany PET Scanners Market by Modality
11.3.2.4.2 Germany PET Scanners Market by Application
11.3.2.4.3 Germany PET Scanners Market by End User
11.3.2.5 France
11.3.2.5.1 France PET Scanners Market by Modality
11.3.2.5.2 France PET Scanners Market by Application
11.3.2.5.3 France PET Scanners Market by End User
11.3.2.6 UK
11.3.2.6.1 UK PET Scanners Market by Modality
11.3.2.6.2 UK PET Scanners Market by Application
11.3.2.6.3 UK PET Scanners Market by End User
11.3.2.7 Italy
11.3.2.7.1 Italy PET Scanners Market by Modality
11.3.2.7.2 Italy PET Scanners Market by Application
11.3.2.7.3 Italy PET Scanners Market by End User
11.3.2.8 Spain
11.3.2.8.1 Spain PET Scanners Market by Modality
11.3.2.8.2 Spain PET Scanners Market by Application
11.3.2.8.3 Spain PET Scanners Market by End User
11.3.2.9 Netherlands
11.3.2.9.1 Netherlands PET Scanners Market by Modality
11.3.2.9.2 Netherlands PET Scanners Market by Application
11.3.2.9.3 Netherlands PET Scanners Market by End User
11.3.2.10 Switzerland
11.3.2.10.1 Switzerland PET Scanners Market by Modality
11.3.2.10.2 Switzerland PET Scanners Market by Application
11.3.2.10.3 Switzerland PET Scanners Market by End User
11.3.2.11. Austria
11.3.2.11.1 Austria PET Scanners Market by Modality
11.3.2.11.2 Austria PET Scanners Market by Application
11.3.2.11.3 Austria PET Scanners Market by End User
11.3.2.12 Rest of Western Europe
11.3.2.12.1 Rest of Western Europe PET Scanners Market by Modality
11.3.2.12.2 Rest of Western Europe PET Scanners Market by Application
11.3.2.12.3 Rest of Western Europe PET Scanners Market by End User
11.4 Asia-Pacific
11.4.1 Asia-Pacific PET Scanners Market by Country
11.4.2 Asia-Pacific PET Scanners Market by Modality
11.4.3 Asia-Pacific PET Scanners Market by Application
11.4.4 Asia-Pacific PET Scanners Market by End User
11.4.5 China
11.4.5.1 China PET Scanners Market by Modality
11.4.5.2 China PET Scanners Market by Application
11.4.5.3 China PET Scanners Market by End User
11.4.6 India
11.4.6.1 India PET Scanners Market by Modality
11.4.6.2 India PET Scanners Market by Application
11.4.6.3 India PET Scanners Market by End User
11.4.7 Japan
11.4.7.1 Japan PET Scanners Market by Modality
11.4.7.2 Japan PET Scanners Market by Application
11.4.7.3 Japan PET Scanners Market by End User
11.4.8 South Korea
11.4.8.1 South Korea PET Scanners Market by Modality
11.4.8.2 South Korea PET Scanners Market by Application
11.4.8.3 South Korea PET Scanners Market by End User
11.4.9 Vietnam
11.4.9.1 Vietnam PET Scanners Market by Modality
11.4.9.2 Vietnam PET Scanners Market by Application
11.4.9.3 Vietnam PET Scanners Market by End User
11.4.10 Singapore
11.4.10.1 Singapore PET Scanners Market by Modality
11.4.10.2 Singapore PET Scanners Market by Application
11.4.10.3 Singapore PET Scanners Market by End User
11.4.11 Australia
11.4.11.1 Australia PET Scanners Market by Modality
11.4.11.2 Australia PET Scanners Market by Application
11.4.11.3 Australia PET Scanners Market by End User
11.4.12 Rest of Asia-Pacific
11.4.12.1 Rest of Asia-Pacific PET Scanners Market by Modality
11.4.12.2 Rest of Asia-Pacific PET Scanners Market by Application
11.4.12.3 Rest of Asia-Pacific PET Scanners Market by End User
11.5 Middle East & Africa
11.5.1 Middle East
11.5.1.1 Middle East PET Scanners Market by Country
11.5.1.2 Middle East PET Scanners Market by Modality
11.5.1.3 Middle East PET Scanners Market by Application
11.5.1.4 Middle East PET Scanners Market by End User
11.5.1.5 UAE
11.5.1.5.1 UAE PET Scanners Market by Modality
11.5.1.5.2 UAE PET Scanners Market by Application
11.5.1.5.3 UAE PET Scanners Market by End User
11.5.1.6 Egypt
11.5.1.6.1 Egypt PET Scanners Market by Modality
11.5.1.6.2 Egypt PET Scanners Market by Application
11.5.1.6.3 Egypt PET Scanners Market by End User
11.5.1.7 Saudi Arabia
11.5.1.7.1 Saudi Arabia PET Scanners Market by Modality
11.5.1.7.2 Saudi Arabia PET Scanners Market by Application
11.5.1.7.3 Saudi Arabia PET Scanners Market by End User
11.5.1.8 Qatar
11.5.1.8.1 Qatar PET Scanners Market by Modality
11.5.1.8.2 Qatar PET Scanners Market by Application
11.5.1.8.3 Qatar PET Scanners Market by End User
11.5.1.9 Rest of Middle East
11.5.1.9.1 Rest of Middle East PET Scanners Market by Modality
11.5.1.9.2 Rest of Middle East PET Scanners Market by Application
11.5.1.9.3 Rest of Middle East PET Scanners Market by End User
11.5.2 Africa
11.5.2.1 Africa Transfusion Diagnostics Market by Country
11.5.2.2 Africa PET Scanners Market by Modality
11.5.2.3 Africa PET Scanners Market by Application
11.5.2.4 Africa PET Scanners Market by End User
11.5.2.5 Nigeria
11.5.2.5.1 Nigeria PET Scanners Market by Modality
11.5.2.5.2 Nigeria PET Scanners Market by Application
11.5.2.5.3 Nigeria PET Scanners Market by End User
11.5.2.6 South Africa
11.5.2.6.1 South Africa PET Scanners Market by Modality
11.5.2.6.2 South Africa PET Scanners Market by Application
11.5.2.6.3 South Africa PET Scanners Market by End User
11.5.2.7 Rest of Africa
11.5.2.7.1 Rest of Africa PET Scanners Market by Modality
11.5.2.7.2 Rest of Africa PET Scanners Market by Application
11.5.2.7.3 Rest of Africa PET Scanners Market by End User
11.6 Latin America
11.6.1 Latin America PET Scanners Market by Country
11.6.2 Latin America PET Scanners Market by Modality
11.6.3 Latin America PET Scanners Market by Application
11.6.4 Latin America PET Scanners Market by End User
11.6.5 Brazil
11.6.5.1 Brazil PET Scanners Market by Modality
11.6.5.2 Brazil PET Scanners Market by Application
11.6.5.3 Brazil PET Scanners Market by End User
11.6.6 Argentina
11.6.6.1 Argentina PET Scanners Market by Modality
11.6.6.2 Argentina PET Scanners Market by Application
11.6.6.3 Argentina PET Scanners Market by End User
11.6.7 Colombia
11.6.7.1 Colombia PET Scanners Market by Modality
11.6.7.2 Colombia PET Scanners Market by Application
11.6.7.3 Colombia PET Scanners Market by End User
11.6.8 Rest of Latin America
11.6.8.1 Rest of Latin America PET Scanners Market by Modality
11.6.8.2 Rest of Latin America PET Scanners Market by Application
11.6.8.3 Rest of Latin America PET Scanners Market by End User
12. Company profile
12.1 Siemens Healthineers
12.1.1 Company Overview
12.1.2 Financial
12.1.3 Modality/ Services Offered
12.1.4 SWOT Analysis
12.1.5 The SNS View
12.2 GE Healthcare
12.2.1 Company Overview
12.2.2 Financials
12.2.3 Modality/ Services Offered
12.2.4 SWOT Analysis
12.2.5 The SNS View
12.3 Koninklijke Phillips N.V.
12.3.1 Company Overview
12.3.2 Financials
12.3.3 Modality/ Services Offered
12.3.4 SWOT Analysis
12.3.5 The SNS View
12.4 Canon Medical Systems USA.
12.4.1 Company Overview
12.4.2 Financials
12.4.3 Modality/ Services Offered
12.4.4 SWOT Analysis
12.4.5 The SNS View
12.5 Mediso Ltd.
12.5.1 Company Overview
12.5.2 Financials
12.5.3 Modality/ Services Offered
12.5.4 SWOT Analysis
12.5.5 The SNS View
12.6 Shimadzu Corporation
12.6.1 Company Overview
12.6.2 Financials
12.6.3 Modality/ Services Offered
12.6.4 SWOT Analysis
12.6.5 The SNS View
12.7 Neusoft Medical Systems Co. Ltd.
12.7.1 Company Overview
12.7.2 Financials
12.7.3 Modality/ Services Offered
12.7.4 SWOT Analysis
12.7.5 The SNS View
12.8 MinFound Medical Systems Co. Ltd
12.8.1 Company Overview
12.8.2 Financials
12.8.3 Modality/ Services Offered
12.8.4 SWOT Analysis
12.8.5 The SNS View
12.9 Perkin Elmer, Inc.
12.9.1 Company Overview
12.9.2 Financials
12.9.3 Modality/ Services Offered
12.9.4 SWOT Analysis
12.9.5 The SNS View
12.10 Positron Corporation
12.10.1 Company Overview
12.10.2 Financials
12.10.3 Modality/ Services Offered
12.10.4 SWOT Analysis
12.10.5 The SNS View
12.11 Yangzhou Kindsway Biotech Co. Ltd.
12.11.1 Company Overview
12.11.2 Financials
12.11.3 Modality/ Services Offered
12.11.4 SWOT Analysis
12.11.5 The SNS View
13. Competitive Landscape
13.1 Competitive Bench marking
13.2 Market Share Analysis
13.3 Recent Developments
13.3.1 Industry News
13.3.2 Company News
13.3.3 Mergers & Acquisitions
14. Use Cases and Best Practices
15. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Peptide Microarray Market size was estimated USD 794.3 million in 2022 and is expected to reach USD 1120.9 million by 2030 at a CAGR of 4.4% during the forecast period of 2023-2030.
The Drug Discovery Informatics Market Size was surveyed at USD 2.96 billion out of 2022 and is supposed to addition to USD 7.08 billion by 2030, stretching out at a CAGR of 11.5% from 2023 to 2030.
The Blood Testing Market Size was valued at USD 98.3 billion in 2023 and is expected to reach USD 172.7 billion by 2031 and grow at a CAGR of 7.3% over the forecast period 2024-2031.
The Artificial Cornea and Corneal Implant Market size was valued at USD 459.7 Million in 2023 and is expected to reach USD 813.7 Million By 2031 and grow at a CAGR of 7.4% over the forecast period of 2024-2031.
The Wound Care Devices Market size was USD 2.63 Billion in 2023 and is expected to Reach USD 3.80 Billion by 2031 and grow at a CAGR of 4.7% over the forecast period of 2024-2031.
The Microcatheters Market Size was valued at USD 1.98 billion in 2022, and is expected to reach USD 2.71 billion by 2030 and grow at a CAGR of 4% over the forecast period 2023-2030.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
